trialstreet

118 results found.

Top Stocks matching your search for "trial street"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
HEPA

Hepion Pharmaceuticals Inc

-16.85%

$0.86 - $0.72

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 18, 2023

Anyway, since this trial is expensive and yet nece... See more

Jan, 11, 2023

2023 is going to be highlighted with a continuous ... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
SOS

SOS Limited - ADR

-26.55%

$6.44 - $4.73

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 13, 2023

STRONGER THAN EVER Pictures are months old, they... See more

Nov, 23, 2022

$BTC.X $SHIB.X $DOGE.X $SOS im cool in college I d... See more

Image with triangles

Divihomes is Now Live

A new search platform that matches you with the best home improvement service providers in your area.

Instant Search & Match with Top Contractors

Instant Communication with Local Contractors

Phone Image with DiviHomes website

Millions of Unbiased User Reviews

100% Free Quotes from Top-Notch Contractors

02/0602/0802/1002/1402/1602/2102/2302/2703/0103/0303/0703/10
SRNE

Sorrento Therapeutics Inc

-69.12%

$1.02 - $0.32

Feb 2nd 2023 - Mar 10th 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 22, 2023

Phase 2/3 is expected to be positive.

Feb, 13, 2023

$SRNE https://www.youtube.com/watch?v=n6_Ypx6soYQ ... See more

HEPA

Hepion Pharmaceuticals Inc

-16.85%

$0.86 - $0.72

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 18, 2023

Anyway, since this trial is expensive and yet necessary for regulatory approval; I interpret it as a bullish signal.

Jan, 11, 2023

2023 is going to be highlighted with a continuous cascade of amazingly positive PR’s confirming the fact (already documented in 300+ early clinical studies), that Rencofilstat is truly a Wonder Drug to be celebrated, with an extraordinarily large TAM.

Jan, 11, 2023

$HEPA Was hoping we would get an update on our (Nash) trial soon and we got this surprising good news.

Jan, 9, 2023

I didnt sell a share and with stellar results for this soon to be released study it should gain traction well over 3 imo.

Dec, 28, 2022

We knows recession is coming next year 4) XBI has bottomed and should begin its upward move next year 5) Phase 2b trial results and updates on HCC trial 6) Probable approvals of NASH drugs and increased bullish sentiment in the sector

Dec, 20, 2022

Sign up for the free trial, it's easy.

Dec, 19, 2022

button for good trial results in the NASH space.

Dec, 19, 2022

Highly statistically significant results because of the large trial size.

SOS

SOS Limited - ADR

-26.55%

$6.44 - $4.73

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Jan, 13, 2023

STRONGER THAN EVER Pictures are months old, they must have finished several phases by now imo. GL!

Nov, 23, 2022

$BTC.X $SHIB.X $DOGE.X $SOS im cool in college I did woman studies African American studies I took the classes don’t call on me cause I’m whote with both ears priced I don’t wanna say anything stupid it’s cool

SRNE

Sorrento Therapeutics Inc

-69.12%

$1.02 - $0.32

Feb 2nd 2023 - Mar 10th 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 22, 2023

Phase 2/3 is expected to be positive.

Feb, 13, 2023

$SRNE https://www.youtube.com/watch?v=n6_Ypx6soYQ great product, great clinical results .. expect a new ATH from Scilex this week!

Feb, 11, 2023

Ji announced favorable phase 3 results in December 2021.

Jan, 10, 2023

The results have been so good OVYDSO leapt from phase 1 to phase 3.

Jan, 9, 2023

Also Zero Adverse Effects during Trial 👌.

Jan, 8, 2023

phase 2/3 ready Each one is a potential all-star.

Dec, 31, 2022

More then enough to cover SRNE trials for many years.

Dec, 18, 2022

Sofusa/Enbrel trial was nothing short of incredible 10/10 response is previous NON-RESPONDERS at 50% the previous does.

Dec, 14, 2022

$SRNE tomorrow great news about CoviMark, Virex, Phase 2 Mpro trial, Semdexa NDA, Abivertinib China/US, MSC trials in US/Brazil, Socazolimab NDA someone bought 1 million shares AH ✅

Dec, 13, 2022

$SRNE me when we get that positive clinic trials news 😂